Welcome to LookChem.com Sign In|Join Free
  • or
19-Hydroxyprogesterone, a natural steroid hormone, is produced in the adrenal glands and serves as a crucial precursor in the synthesis of vital hormones like cortisol and sex hormones. It is also a biomarker for congenital adrenal hyperplasia, a genetic disorder impacting the adrenal glands. Its levels are commonly measured in newborns to screen for this condition. Furthermore, 19-hydroxyprogesterone has been investigated for its potential therapeutic applications in preterm labor, infertility, and certain types of cancer, highlighting its importance in various biological functions and medical implications.

596-63-4

Post Buying Request

596-63-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

596-63-4 Usage

Uses

Used in Medical Diagnostics:
19-Hydroxyprogesterone is used as a biomarker for congenital adrenal hyperplasia, aiding in the early detection and diagnosis of this genetic disorder in newborns.
Used in Endocrinology:
19-Hydroxyprogesterone is used as a precursor hormone in the synthesis of cortisol and sex hormones, playing a significant role in the endocrine system's regulation.
Used in Obstetrics:
19-Hydroxyprogesterone is used as a therapeutic agent for preventing preterm labor, helping to prolong pregnancy and improve neonatal outcomes.
Used in Reproductive Medicine:
19-Hydroxyprogesterone is used as a treatment for infertility, potentially improving fertility rates by addressing hormonal imbalances.
Used in Oncology:
19-Hydroxyprogesterone is used as a potential therapeutic agent in the treatment of certain types of cancer, with ongoing research exploring its effects on tumor growth and progression.

Check Digit Verification of cas no

The CAS Registry Mumber 596-63-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,9 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 596-63:
(5*5)+(4*9)+(3*6)+(2*6)+(1*3)=94
94 % 10 = 4
So 596-63-4 is a valid CAS Registry Number.
InChI:InChI=1/C21H30O3/c1-13(23)17-5-6-18-16-4-3-14-11-15(24)7-10-21(14,12-22)19(16)8-9-20(17,18)2/h11,16-19,22H,3-10,12H2,1-2H3/t16-,17+,18-,19-,20+,21+/m0/s1

596-63-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (8S,9S,10S,13S,14S,17S)-17-acetyl-10-(hydroxymethyl)-13-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

1.2 Other means of identification

Product number -
Other names 19-Hydroxy-4-pregnene-3,20-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:596-63-4 SDS

596-63-4Relevant academic research and scientific papers

Synthesis of 6,19-cyclopregnanes. Constrained analogues of steroid hormones

Di Chenna, Pablo H.,Veleiro, Adriana S.,Sonego, Juan M.,Ceballos, Nora R.,Garland, M. Teresa,Baggio, Ricardo F.,Burton, Gerardo

, p. 2453 - 2457 (2007)

A procedure for the synthesis of 6,19-cyclopregnanes is described involving an intramolecular alkylation reaction of Δ4-3-keto steroids with a 19-mesylate in the presence of KOH in isopropanol. Three 6,19-cyclopregnanes were prepared (4, 5, 9); in the rat, 6,19-cycloprogesterone (4) and its 21-hydroxy derivative 5 displaced [3H]-dexamethasone from glucocorticoid receptors, the former compound being more active. Both compounds did not compete with [3H]-aldosterone for kidney mineralocorticoid receptors nor with [3H]-R5020 for uterus progesterone receptors. This journal is The Royal Society of Chemistry.

Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids

-

, (2008/06/13)

The present invention is related to novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues, their use as antiglucocorticoids for the treatment and/or prophylaxis of diseases associated to an excess of glucocorticoids. In particular, the invention relates to the use of novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues having the formula FORMULAwherein X is S, SO and SO2, and R is either M or OH, for treating Cushing's syndrome, iatrogenic hypercortisolism or depression. Also the present invention is related to methods of preparing the novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues.

SYNTHESIS OF 19-HYDROXYSTEROIDS II. NEW SYNTHESIS OF 19-HYDROXYPROGESTERONE

Kovganko, N. V.,Kashkan, Zh. N.,Chernov, Yu. G.

, p. 589 - 592 (2007/10/02)

19-Hydroxyprogesterone has been synthesized in seven stages from pregnenolone with an overall yield of 11percent.

An Improved Route to 19-Hydroxypregn-4-ene-3,20-dione and Synthesis of its Analogue

Kirk, David N.,Rajagopalan, Maruthiandan S.,Varley, Michael J.

, p. 2225 - 2228 (2007/10/02)

3β-Acetoxy-5-bromo-6β,19-epoxy-5α-pregnane-20-one is more reliably converted into 19-hydroxyprogesterone via reductive opening of the epoxide to give 3β-acetoxy-19-hydroxypregn-5-en-20-one than by a previously published procedure. 19-Hydroxyprogesterone has been converted into its analogue in good yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 596-63-4